宝华通过调节线粒体功能和ER压力来增强卵巢癌细胞中的帕克利塔塞尔敏感性
Sang-Jin Lee1, Kee K Kim2, Jin-Young Lee1
1Department of Biological Sciences, College of Natural Sciences, Keimyung University, Daegu, Republic of Korea.
Animal cells and systems
|July 2, 2025
概括
巴瓦是一种植物雌激素,通过诱导亡并破坏细胞能量生产,有效抑制卵巢癌的生长. 它还增强了化疗的有效性,显示出作为一种新的卵巢癌治疗的前景.
科学领域:
- 植物化学 植物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 巴瓦是一种来自Psoralea corylifolia的植物雌激素,具有抗癌特性.
- 目前尚不清楚它在卵巢癌中的有效性和机制.
研究的目的:
- 在卵巢癌细胞 (ES2和OV90) 中研究bavachin的抗癌机制.
- 评估bavachin在卵巢癌中增强帕克利塔塞尔敏感性的潜力.
主要方法:
- 评估了bavachin对细胞增殖,球形形成和细胞亡的影响.
- 分析了线粒体功能,生物能学 (氧化酸化和糖解) 和内质网膜应激通路.
- 检查了对ERK1/2和p38 MAPK信号的影响.
- 评估了与帕克利塔塞尔的联合治疗.
主要成果:
- 宝华抑制了增殖和球状体的形成,通过Bcl-2家族蛋白质调节诱导了卡斯帕酶依赖的亡.
- 它破坏了线粒体的功能,损害了细胞的生物能量,并激活了内质网膜应激.
- 巴瓦辛抑制了ERK1/2和p38 MAPK酸化.
- 与帕克利塔克塞尔的组合显示出协同作用的抗癌活性.
结论:
- 巴瓦辛对卵巢癌细胞表现出多机制的抗癌作用.
- 它具有作为治疗剂的潜力,特别是与化疗结合使用.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Electron Transport Chain: Complex I and II
15.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K


